A wholesale distributor based in Florida has been sent a warning letter from the FDA for non-compliance with the requirements of the Drug Supply Chain Security Act (DSCSA), including failure to identify and investigate a product later determined to be falsified.
The letter – addressed to Sterling Distributors president Dean Berry – also says that the company has been operating without being properly licensed in Florida, Arkansas or Mississippi, conducted transactions with unauthorised trading partners, and failed to respond to enquiries from federal officials.
Read Article
#Florida
#DSCSA
#DSCSAViolations